BMS-986378

· Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986378, covering 2024-10-02 to 2024-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer [Phase 1]

See pricing